<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02886468</url>
  </required_header>
  <id_info>
    <org_study_id>2016-03-CHRMT</org_study_id>
    <nct_id>NCT02886468</nct_id>
  </id_info>
  <brief_title>DEpth of EPinephrine Delivery With Auto-injectors Devices</brief_title>
  <acronym>DEEP</acronym>
  <official_title>Determinants of Muscle - Skin Distance at the Injection Site in Patients With an Indication for the Use of Epinephrine Auto- Injector Pens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional Metz-Thionville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Régional Metz-Thionville</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.&#xD;
      Although there are several causes of fatal anaphylaxis, food allergy is one of the most&#xD;
      common. Epinephrine is recommended as the initial treatment of choice for anaphylaxis. A&#xD;
      delay in epinephrine administration may contribute to an increased risk of death. Therefore,&#xD;
      the World Allergy Organization recommends that, for the treatment of anaphylaxis, epinephrine&#xD;
      solution be administered intramuscularly in the mid-anterolateral thigh.&#xD;
&#xD;
      In France 3 auto-injector pens are available: Anapen®, Epipen® and Jext®. For weight&gt; 30 kg,&#xD;
      the devices have a needle size respectively of 7.49 mm, 15.02 mm and 15.36 mm. For the&#xD;
      weights between 15 and 30 kg needle size is 7.49 mm to 12.7 mm and Anapen® for Epipen® and&#xD;
      Jext®.&#xD;
&#xD;
      Several studies suggest that the needle length needle is sometim&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 26, 2016</start_date>
  <completion_date type="Actual">August 16, 2021</completion_date>
  <primary_completion_date type="Actual">May 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin-to-muscle and muscle-to-bone distance assessment, with compression, for intramuscular injection depending on needle length of the auto-injector pen.</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">107</enrollment>
  <condition>Anaphylactic Shock</condition>
  <arm_group>
    <arm_group_label>ultrasound images</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ultrasound images of the anterolateral aspect of the mid-right thigh</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>skin ultrasound</intervention_name>
    <arm_group_label>ultrasound images</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  a weight of over 30 kg at Baseline&#xD;
&#xD;
          -  with food or an Hymenoptera venom allergy (diagnosed by skin tests or serum-specific&#xD;
             IgE testing, requiring prescription epinephrine auto-injector pen according to&#xD;
             European recommendations,&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  having a skin lesion on the lateral aspect of the thigh,&#xD;
&#xD;
          -  with a known or suspected allergy to the contact gel&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chr Metz Thionville</name>
      <address>
        <city>Metz</city>
        <zip>57085</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2016</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anaphylaxis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

